RESMED INC — Director's Dealing 2016

Aug 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-08-08

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-08	ResMed Common Stock	M	24390	$33.70	Acquired	37390	Direct
2016-08-08	ResMed Common Stock	S	24390	$70.315	Disposed	13000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-08	ResMed Common Stock Options	$33.70	M	24390	Disposed	2017-11-11	ResMed Commmon Stock (24390)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $70.23 to $70.42. The price reported above reflects the weighted average sale price.

F2: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date.